Cholesterol

New Study Reveals 65 and Older Population Lowered Blood Pressure, Cholesterol, and Weight Using Mobile Technology

Retrieved on: 
tisdag, april 23, 2024
Cardiology, Health, Medical Devices, Health Technology, Wearables, Mobile Technology, Technology, Apps, Applications, Mobile, Wireless, Stroke, American College, SBP, Risk, Blood pressure, CVD, Heart, BMI, Death, Conference, Artificial intelligence, Heart rate, SVP, Patient, Splenic infarction, Cholesterol, Physician, Medicare, LDL, Cardiovascular disease, BP, Ageing

The study observed 8,148 Hello Heart users aged 65 and over who were equipped with the Hello Heart connected monitor and mobile app.

Key Points: 
  • The study observed 8,148 Hello Heart users aged 65 and over who were equipped with the Hello Heart connected monitor and mobile app.
  • Study participants showed a 45% higher engagement rate compared to Hello Heart users younger than 65.
  • “Results from this study challenge the assumption that our aging population struggles to use smartphones or are resistant to using technology to manage their health,” said Edo Paz, MD, SVP, Medical Affairs, Hello Heart.
  • “There’s a significant untapped opportunity to engage this age group with scalable mobile technology to help them better understand their CVD risk and take steps to improve their heart health.”

Karmanos Brings Successful Cancer Screening and Prevention Event to Farmington Hills

Retrieved on: 
måndag, april 15, 2024
Cancer, COVID, Save, Woman, Health, Diabetes, Breast, Insurance, Female, Patient, Karmanos Cancer Institute, Education, Cholesterol, Movement, HPV, ID, Breast cancer, Meditation

DETROIT, April 15, 2024 /PRNewswire/ -- The Barbara Ann Karmanos Cancer Institute invites the community to the Screening Saves Lives: Cancer Screening and Educational Event in Farmington Hills. It takes place on Saturday, June 8, 2024, from 9 a.m. – 2 p.m. at the Lawrence and Idell Weisberg Cancer Center at 31995 Northwestern Highway. Karmanos will provide breast cancer screenings, including mammograms, colorectal screening consultations, free head and neck examinations, and wellness checks.

Key Points: 
  • DETROIT, April 15, 2024 /PRNewswire/ -- The Barbara Ann Karmanos Cancer Institute invites the community to the Screening Saves Lives: Cancer Screening and Educational Event in Farmington Hills.
  • Karmanos will provide breast cancer screenings, including mammograms, colorectal screening consultations, free head and neck examinations, and wellness checks.
  • Plus, Karmanos will provide information about their Screening and Prevention Program , the Karmanos Genetic Counseling Service , the Women's Wellness Clinic , and clinical trials .
  • Screening Saves Lives: Cancer Screening and Educational Event is open to the public.

Drinking apple cider vinegar may help with weight loss but its health benefits are overstated

Retrieved on: 
onsdag, april 10, 2024
Well, Research, Disease, Overweight, Health, Glucose, Diarrhea, Myocardial infarction, Apple, Cell, Serum, Infection, Appetite, Vegetable, Incidence, Acetic acid, Risk, Physiology, Lipid, Insulin, Diabetes, Weight loss, Internet, Stroke, Blood, Mortality, Cancer, Systematic review, Breakfast, Diet, Cholesterol, Vomiting, Drinking water, Dietary supplement

One day, she explained that she adds apple cider vinegar to improve my health.

Key Points: 
  • One day, she explained that she adds apple cider vinegar to improve my health.
  • Apple cider vinegar is a natural product made of fermented apple juice that has gone sour.
  • I decided to turn medical sleuth and investigate whether apple cider vinegar is as good for health as it sounds.

Claim: disinfectant properties

  • But does apple cider vinegar’s decontaminant qualities translate to the human gut?
  • Our stomachs produce acid, which acts as a natural barrier to infection, so how can adding more acid help?

Claim: weight loss and management of type 2 diabetes

  • There are plenty of anecdotal claims that apple cider vinegar can aid weight loss, supported by limited evidence from several small studies.
  • Apple cider vinegar is thought to cause weight loss through its effect on delay of gastric emptying.
  • Reduced calorific intake will lead to weight loss – but how are the metabolic effects on blood glucose and lipids mediated?
  • In type 2 diabetes there is a reduction in sensitivity to insulin which in turn leads to a reduced uptake of glucose by cells.

Claim: reduces risk of heart disease

  • Raised blood lipids are a risk factor for cardiovascular diseases such as myocardial infarction and stroke.
  • Well, I’m afraid there’s no scientific evidence that vinegar consumption of any kind reduces cardiovascular morbidity and mortality in those with or without diabetes.

Claim: cancer treatment and prevention

  • One of the more outrageous claims of benefits of daily apple cider vinegar consumption is that it may prevent or treat cancer.
  • A frequently quoted case-control study from China found that an increased consumption of vinegar was associated with a reduced incidence of oesophageal cancer.


Stephen Hughes does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

Valbiotis to launch its 100% natural dietary supplement for the management of hypercholesterolemia on the French market in May

Retrieved on: 
onsdag, april 10, 2024
Cholecalciferol, LDL, CRM, Cholesterol, Cardiovascular disease, Medicine, Digital, Dietary supplement, Business, Risk, Patient, Pharmacy, DSM-IV codes, ERP, Research, Stroke, Pharmacist, Business development, Executive Committee, HEART, Artery, Research and development, Omega-3 fatty acid, Safety, Enterocyte, Lipid metabolism, General practitioner, Marketing, Practitioner, Sleep, Hypercholesterolemia, Pharmaceutical industry

The natural and innovative characteristics of this product clearly position Valbiotis®PRO Cholestérol as a leader in the lifestyle and dietary management of hypercholesterolemia, a major risk factor for cardiovascular disease."

Key Points: 
  • The natural and innovative characteristics of this product clearly position Valbiotis®PRO Cholestérol as a leader in the lifestyle and dietary management of hypercholesterolemia, a major risk factor for cardiovascular disease."
  • Available behind the counter in pharmacies, the dietary supplement will also be sold without a prescription with a pharmacist’s recommendation.
  • It comprises a new generation of dietary supplements with active ingredients of natural origin, acting on several targets for comprehensive management.
  • A principal mechanism controls intestinal cholesterol absorption, while a complementary mechanism acts on hepatic metabolism for a comprehensive approach to the management of hypercholesterolemia.

Beyond Meat® Unveils New and Expanded Line of Beyond Crumbles, Now Certified by the American Heart Association’s Heart-Check Program and the American Diabetes Association’s Better Choices for Life Program

Retrieved on: 
torsdag, mars 28, 2024
American Heart Association, Health, LDL, Certification, Cardiovascular disease, Taste, BYND, Nutrition, TMAO, Nutrient, Diabetes, American Journal, American Cancer Society, Stroke, Crumble, Beyond Meat, Sodium, Food, Death, Risk, Breakfast, Diet, American Diabetes Association, Beyond, Reference Daily Intake, Lunch, Cholesterol, American Heart, Dietary supplement

Convenient and easy to prepare, simply sauté the crumbles for four minutes in a skillet before adding them to your favorite dish or sauce.

Key Points: 
  • Convenient and easy to prepare, simply sauté the crumbles for four minutes in a skillet before adding them to your favorite dish or sauce.
  • Beyond Crumbles’ strong nutritional profile, coupled with its simple and clean ingredient list, earned the product certification by the American Heart Association’s Heart-Check program and the American Diabetes Association’s Better Choices for Life program,” said Beyond Meat Founder and CEO Ethan Brown.
  • As part of Beyond Meat’s commitment to innovating for human health, this announcement follows Beyond Steak’s earlier certifications by the American Heart Association and the American Diabetes Association .
  • With 1.2 million Americans diagnosed with diabetes every year , the Better Choices for Life Program uses the American Diabetes Association’s evidence-based guidelines to help consumers make informed choices about the foods they purchase.

RC Show 2024 Release New & Innovative Product Showcase

Retrieved on: 
onsdag, mars 27, 2024
Cooking, LFC, PFAS, Milk, Pineapple, Enercare Centre, Carbon, Wine, Pea, Restaurant, Creativity, Marketing, Automation, Red meat, Ginger, Drink, Miski, Hormone, VKD, Atlas, Freezing, Notch, Woman, Mouth, Safety, Interim, Cholesterol, Sambucus, Breakfast, Food, Rejuvenation, Taste, Bison, Coffee, RC, Plant, Food safety, Advertising, Farmer, Growth, ServiceNow, SoFi, Environment, Agave, Robotics, Water, Billio, MEIKO, AMT, Genetically modified organism, Tractor

Since 2010, KEENON Robotics , driven by its slogan "Keen on robots, keen on the future," has led the robotics sector.

Key Points: 
  • Since 2010, KEENON Robotics , driven by its slogan "Keen on robots, keen on the future," has led the robotics sector.
  • With a comprehensive range including advertising, delivery, hotel, and the latest addition, cleaning robots, they cater to diverse commercial needs.
  • Diversey Canada Inc. has been a pivotal player in increasing operational efficiency for the industry and that continues in 2024.
  • You will find more of these innovative products and solutions all under one roof at RC Show 2024, taking place April 8-10, where the industry will come together, be inspired and learn how to LEVEL UP!

New Study Shows Consistent Use of Goode Health's Ultimate Superfood Blend Results In Significant Health Improvements

Retrieved on: 
tisdag, april 9, 2024
Inflammation, Health, Metabolism, Nutrient, Hunger, University, Impact, Trial of the century, Cholesterol, Chocolate, Dietary supplement

COLUMBUS, Ohio, April 9, 2024 /PRNewswire/ -- Goode Health, a leader in nutritional supplements, is excited to announce the results of its latest clinical study focused on its Ultimate Superfood Nutrition Blend. The results of the study, conducted at the University of Texas Arlington, show that Goode Health significantly improves key indicators of vascular health, inflammation, cholesterol level, and stress in as little as two weeks.

Key Points: 
  • And the results of this study show that Goode Health truly makes a difference in the health of those who use it consistently.
  • Consistent consumption of Goode Health's Ultimate Superfood Blend was shown to lead to improvements in vascular health, reductions in cholesterol, and reduced inflammation within a short time frame of just two weeks.
  • The Ultimate Superfood Blend by Goode Health stands out amidst the myriad of green shakes and smoothie supplements available on the market.
  • To learn more about Goode Health's Ultimate Superfood Blend and to place an order, visit www.goodehealth.com .

New Clinical Study Reveals Consuming 12 Eggland's Best Eggs Weekly Shows No Negative Effects on Cholesterol Levels; Study Also Suggests Possible Benefits for Some Consumers

Retrieved on: 
måndag, april 8, 2024
Research, Health, LDL, Cardiovascular disease, Vitamin, Nutrient, Cardiology, Diabetes, Risk, Patient, Senior, American College, Clinical trial, HDL, Cholesterol, Egg as food, Duke, Vitamin B12, Pharmaceutical industry

CEDAR KNOLLS, N.J., April 8, 2024 /PRNewswire/ -- Americans are increasingly aware of the impact of cholesterol on heart health and well-being, but for decades, there have been conflicting headlines about which foods can have positive or negative effects. Eggs, in particular, have often received negative press related to cholesterol. However, a new study presented at the American College of Cardiology's Annual Scientific Session that was led by researchers at Duke and sponsored by Eggland's Best, offers promising new evidence on fortified eggs.

Key Points: 
  • The clinical trial studied 140 participants from a broadly generalized population who had a high risk of heart disease.
  • Researchers randomized participants into two groups, asking half to eat two or fewer eggs per week for four months.
  • Ultimately, the study found that over 4 months, eating Eggland's Best eggs resulted in no adverse effects on lipid profiles and markers of cardiovascular risk for these patients.
  • The consumption of Eggland's Best eggs may also increase Vitamin B12 levels, also helping to support a healthier lifestyle.

ZyVersa Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update

Retrieved on: 
måndag, mars 25, 2024
Research, Diabetic nephropathy, Cholesterol, Obesity, Institutional review board, Patient, Protocol, MJFF, University, IND, IRB, Investigational New Drug, Therapy, Atherosclerosis, Metabolic syndrome, Government, Inflammasome, Pharmaceutical industry

WESTON, Fla., March 25, 2024 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or “ZyVersa”), a clinical-stage specialty biopharmaceutical company developing first-in-class drugs for the treatment of renal and inflammatory diseases with high unmet medical needs, reports financial results for full year ending December 31, 2023, and provides business update.

Key Points: 
  • Scientific collaboration to assess Inflammasome ASC Inhibitor IC 100 as a potential treatment for atherosclerosis expected to conclude H1-2024.
  • WESTON, Fla., March 25, 2024 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or “ZyVersa”), a clinical-stage specialty biopharmaceutical company developing first-in-class drugs for the treatment of renal and inflammatory diseases with high unmet medical needs, reports financial results for full year ending December 31, 2023, and provides business update.
  • “Throughout 2023 and early 2024, ZyVersa achieved considerable progress in advancing development of our two lead candidates.
  • The impairment is a result of the decline in stock value and the resulting market capitalization of ZyVersa during the 2023 Period.

ZyVersa Therapeutics Announces IRB Approval of Phase 2a Clinical Trial Protocol to Evaluate Cholesterol Efflux Mediator™ VAR 200 in Patients with Diabetic Kidney Disease

Retrieved on: 
måndag, mars 18, 2024
Alport syndrome, Diabetic nephropathy, VAR, Institutional review board, Lipid, Patient, Focal segmental glomerulosclerosis, Kidney disease, Fibrosis, Clinical trial, Kidney, Therapy, Chronic kidney disease, Safety, Dialysis, Cholesterol, IRB, Pharmaceutical industry

Cholesterol Efflux MediatorTM VAR 200 is in development to ameliorate renal lipid accumulation that damages the kidneys’ filtration system, leading to chronic kidney disease and its progression.

Key Points: 
  • Cholesterol Efflux MediatorTM VAR 200 is in development to ameliorate renal lipid accumulation that damages the kidneys’ filtration system, leading to chronic kidney disease and its progression.
  • WESTON, Fla., March 18, 2024 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for the treatment of renal and inflammatory diseases with high unmet medical needs, announces Institutional Review Board (IRB) approval of the Phase 2a clinical trial protocol to evaluate the efficacy and safety of Cholesterol Efflux Mediator VAR 200 in patients with diabetic kidney disease.
  • It is the first in human trial for VAR 200 intended to substantiate that the promising preclinical results demonstrated in three different animal models of kidney disease (diabetic kidney disease, focal segmental glomerulosclerosis, and Alport syndrome) translate to patients with kidney disease.
  • We are excited about the potential of Cholesterol Efflux MediatorTM VAR 200 to protect against kidney injury and reduce kidney disease progression.”